Cycad Group Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 3

- Investments
- 46
- Portfolio
- 6
- Exits
- 29

Cycad Group General Information
Description
Cycad Group is a venture capital firm focusing on investments in companies with enabling solutions, disruptive technologies and innovative products. The firm pursues investment opportunities in the areas of life sciences, energy technologies and advanced materials and chemical processes. It was founded in 2000 and is based in Santa Barbara, California.
Contact Information
Website
www.cycadvc.com
Year Founded
2000
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- 1270 Coast Village Circle
- Suite 100
- Santa Barbara, CA 93108
- United States
+1 (805) 000-0000
Cycad Group Investments (46)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
ExThera Medical | 10-Sep-2021 | Later Stage VC | 00.000 | Surgical Devices | Generating Revenue | |
00000000 | 03-Jun-2021 | 00000 00000 | 000.00 | Drug Discovery | Clinical Trials - Phase 2 | 0000000 000000 00 |
000000000 | 23-Aug-2018 | 00000 00000 | 00.00 | Industrial Supplies and Parts | Generating Revenue | 0000000 000000 00 |
00000000 | 05-Oct-2017 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue | |
00000000 | 14-Sep-2017 | 00000 00000 | 00.000 | Drug Discovery | Clinical Trials - Phase 2 | 0000000 000000 00 |
00000 000000000000 | 21-Aug-2017 | 00000 00000 | 00000 | Biotechnology | Generating Revenue/Not Profitable | |
00000000 | 03-Aug-2017 | 00000 00000 | 00000 | Drug Delivery | Bankruptcy: Liquidation | |
000000000 0000000 | 13-May-2015 | 00000 00000 | 000.00 | Surgical Devices | Generating Revenue | 000000 00000 |
Visterra | 15-May-2014 | Later Stage VC | 0000 | Biotechnology | Generating Revenue | |
ImaginAb | 08-May-2014 | Later Stage VC | 000.00 | Drug Discovery | Clinical Trials - Phase 2 | 0000000 000000 00 |
Cycad Group Exits (29)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
FzioMed | 01-Sep-2021 | Secondary Transaction - Private | |
0000000 (00000 000 | 01-Jun-2021 | 000000000 00000000 | |
000000000 | 11-May-2021 | 000000000000000000 | |
000000000 | 10-Nov-2020 | 000000000000000000 | 00.00 |
00000000 | 01-Nov-2020 | 0000000000: 000000 | |
00000000 00000000 | 05-Feb-2020 | 000000000 00000000 | 000.00 |
00000000 | 31-Aug-2018 | 000000000000000000 | 00000 |
00000 000000000000 | 03-May-2018 | 000 | 0000 |
ClarVista Medical | 20-Sep-2017 | Merger/Acquisition | 00000 |
Calimmune | 11-Sep-2017 | Merger/Acquisition | 00000 |
Cycad Group Investments by Industry, Year, and Region
Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialCycad Group Team (3)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Robert Balch | Senior Vice President | 0 | Santa Barbara, CA | ||
Leonard Judson JD | Co-Founder, President and Managing Director | 0 | 0 | Santa Barbara, CA | |
Paul Glenn JD | Chairman & Director | 0 | Santa Barbara, CA |
Cycad Group Co-Investors (4)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Adage Capital Management | 1 | 0 |
![]() |
![]() |
|
Norgine Ventures | 0 | 0 |
![]() |
![]() |
|
Raptor Group | 0 | 0 |
![]() |
![]() |
|
Société de Participation et de Gestion | 0 | 0 | 0 |
![]() |
![]() |